Effects of Intradialytic Nutrition on Dialysis Adequacy and Fatigue
1 other identifier
interventional
36
1 country
2
Brief Summary
This randomized, two-period, two-sequence crossover trial aims to evaluate the effects of intradialytic nutrition on dialysis adequacy, intradialytic hemodynamic parameters, and fatigue in adults receiving maintenance hemodialysis. Participants will receive standardized intradialytic nutrition during one study period and no food intake during the other period, with each participant serving as their own control. Dialysis adequacy will be assessed using the urea reduction ratio (URR) and single-pool Kt/V (spKt/V), while fatigue will be evaluated using the Piper Fatigue Scale. Intradialytic blood pressure and other clinical parameters will also be monitored throughout the study. The findings are expected to provide evidence regarding the safety and clinical effects of intradialytic nutrition and to support individualized nutritional management strategies for patients undergoing maintenance hemodialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
June 26, 2026
CompletedFirst Posted
Study publicly available on registry
July 7, 2026
CompletedJuly 7, 2026
July 1, 2026
3 months
June 26, 2026
July 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Dialysis Adequacy (spKt/V)
Dialysis adequacy was assessed using single-pool Kt/V (spKt/V)
At the end of each 4-week study period.
Urea Reduction Ratio (URR)
Urea Reduction Ratio (URR) calculated from routine pre- and post-dialysis blood samples.
Assessed at the end of each 4-week study period.
Fatigue Severity
Piper Fatigue Scale (22 items; total score 0-220). Higher scores indicate greater fatigue severity (worse fatigue).
Assessed at the end of each 4-week study period.
Secondary Outcomes (2)
Intradialytic Systolic Blood Pressure
During each dialysis session throughout each 4-week study period.
Intradialytic Diastolic Blood Pressure
During each dialysis session throughout each 4-week study period.
Study Arms (2)
Standardized Intradialytic Nutrition
EXPERIMENTALParticipants received a standardized renal meal during hemodialysis sessions.
No Intradialytic Food Intake
NO INTERVENTIONParticipants did not consume food during hemodialysis sessions.
Interventions
Participants received a standardized renal meal approximately 1.5 hours after the start of each hemodialysis session. The meal provided approximately 450 kcal and 20 g of protein and was designed according to renal dietary recommendations with low potassium and phosphorus content. Participants were instructed to consume the entire meal and not to consume any additional food during the dialysis session.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older.
- Receiving maintenance hemodialysis three times per week for at least 3 months.
- Clinically stable.
- Able to provide written informed consent.
You may not qualify if:
- Active infection.
- Hospitalization within the previous month.
- Gastrointestinal disorders affecting oral intake.
- Severe intradialytic hypotension requiring frequent intervention (MAP \<65 mmHg).
- Cognitive impairment.
- Pregnancy.
- Scheduled kidney transplantation with an available donor during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Diamer Private Dialysis Center
Mersin, Yenişehir, 33343, Turkey (Türkiye)
Mersin University, Faculty of Medicine Hospital, Hemodialysis Unit
Mersin, Yenişehir, 33343, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Esra Köse, MSc
Mersin University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Profesör
Study Record Dates
First Submitted
June 26, 2026
First Posted
July 7, 2026
Study Start
April 1, 2022
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
July 7, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be made publicly available because the study did not include a data-sharing plan in the informed consent process, and data contain confidential participant information.